Global Paracetamol Market
Global Paracetamol was valued at US$ 9.44 Billion in 2021, estimated to reach US$ 12.91 Billion in 2027, with a CAGR 4.1% from 2022-2027.
Paracetamol is also known as Acetaminophen, that is the most broadly used analgesic and antipyretic which relieves pain and reduce fever. In 1877 it was discovered & the drug is characteristically used for mild to moderate pain. By the International Non-proprietary, Britain and Australia, the name ‘Paracetamol’ is approved, whereas in U.S and Japan Acetaminophen is the name which is approved and used.
Market Drivers
Increasing population along with the rising prevalence of conditions like headaches, flu etc. and the growing demand for pain management drugs are the key factors that drive the growth of the paracetamol market.
Also, the growth is driven by increasing prevalence and burden of indicative diseases and conditions in the forecast period.
In addition, rising number of patients suffering from chronic conditions like cancer, chronic pulmonary obstructive disease (COPD) is propelling demand for paracetamol.
Market Restraints
Increasing availability of huge number of generics and intense competition and rising popularity of sustainable chemistry are the key factors among others that will hamper the market growth, and will additionally challenge the growth of Paracetamol market in the forecast period. Moreover, Chronic side effects of drugs is expected to restrain the market growth.
Market Segmentation
Paracetamol Market is segmented into major 4 categories. Based on Application, the market is segmented into Headache and Fever, Cold and Cough, Muscle Cramps, Others. Based on Form, the market is divided into Tablet, Capsule, Liquid Suspension, Powder. Based on End User Industry, the market is segmented into Pharmaceuticals, Dye Industries, Chemical Industries. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East.
Regional Analysis
North America is anticipated to dominate the Market and Likely to do Same in the Forecast Period owing to the factors like the presence of main players, high prevalence of fever, headaches, and migraine in the region.
Asia Pacific is anticipated to show the growth in demand in upcoming years because of the increasing population as well as general health problems.
Europe is the anticipated region in terms of growth in Paracetamol (acetaminophen) market because of the rising need to manage pain and rising awareness in this region.
Market Key Players
Some of the key players operating in Global Paracetamol Market are GlaxoSmithKline plc, Teva Pharmaceuticals USA, Inc., Genesis Biotec Inc., Mallinckrodt Pharmaceuticals, Geno Pharma, Biological E, CFL Pharma, Cipla, Dr. Reddy's Labs, Sanofi.
Industry development
In April 2022, IOL Chemicals and Pharmaceuticals started commercial production of paracetamol with an installed capacity of 1800 MTPA and backward integration of Para Amino Phenol (PAP).
In March 2022, Paraveganio has become one of the first medicinal products in the world to be registered with The Vegan Society’s Vegan Trademark. The certified vegan drug contains 500mg of the proven active ingredient paracetamol.
Global Paracetamol Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Paracetamol Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Paracetamol Market, By Application
5.1 Y-o-Y Growth Comparison, By Application
5.2 Paracetamol Market Share Analysis, By Application
5.3 Paracetamol Market Size and Forecast, By Application
5.3.1 Headache and Fever
5.3.2 Cold and Cough
5.3.3 Muscle Cramps
5.3.4 Others
6 Paracetamol Market, By Form
6.1 Y-o-Y Growth Comparison, By Form
6.2 Paracetamol Market Share Analysis, By Form
6.3 Paracetamol Market Size and Forecast, By Form
6.3.1 Tablet
6.3.2 Capsule
6.3.3 Liquid Suspension
6.3.4 Powder
7 Paracetamol Market, By End User Industry
7.1 Y-o-Y Growth Comparison, By End User Industry
7.2 Paracetamol Market Share Analysis, By End User Industry
7.3 Paracetamol Market Size and Forecast, By End User Industry
7.3.1 Pharmaceuticals
7.3.2 Dye Industries
7.3.3 Chemical Industries
8 Paracetamol Market, By Region
8.1 Paracetamol Market Share Analysis, By Region
8.2 Paracetamol Market Share Analysis, By Region
8.3 Paracetamol Market Size and Forecast, By Region
9 North America Paracetamol Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America Paracetamol Market Share Analysis, By Application
9.3 North America Paracetamol Market Size and Forecast, By Form
9.4 North America Paracetamol Market Size and Forecast, By End User Industry
9.5 North America Paracetamol Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Paracetamol Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe Paracetamol Market Share Analysis, By Application
10.3 Europe Paracetamol Market Size and Forecast, By Form
10.4 Europe Paracetamol Market Size and Forecast, By End User Industry
10.5 Europe Paracetamol Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11 Asia Pacific Paracetamol Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific Paracetamol Market Share Analysis, By Application
11.3 Asia Pacific Paracetamol Market Size and Forecast, By Form
11.4 Asia Pacific Paracetamol Market Size and Forecast, By End User Industry
11.5 Asia Pacific Paracetamol Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Paracetamol Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Latin America Paracetamol Market Share Analysis, By Application
12.3 Latin America Paracetamol Market Size and Forecast, By Form
12.4 Latin America Paracetamol Market Size and Forecast, By End User Industry
12.5 Latin America Paracetamol Market Size and Forecast, Country
12.5.1. Brazil
12.5.2. Rest of Latin America
13 Middle East Paracetamol Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Middle East Paracetamol Market Share Analysis, By Application
13.3 Middle East Paracetamol Market Size and Forecast, By Form
13.4 Middle East Paracetamol Market Size and Forecast, By End User Industry
13.5 Middle East Paracetamol Market Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.2. UAE
13.5.3. Egypt
13.5.4. Kuwait
13.5.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 GlaxoSmithKline plc
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Teva Pharmaceuticals USA, Inc.
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Genesis Biotec Inc
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Mallinckrodt Pharmaceuticals
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Geno Pharma
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Biological E
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 CFL Pharma
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Cipla
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Dr. Reddy's Labs
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Sanofi
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
